<journal article>
Preliminary Results of Radiation Therapy for Locally Advanced or Recurrent Adenoid Cystic Carcinomas of the Head and Neck using Combined Conventional Radiation Therapy and Hypofractionated Inverse Planned Stereotactic Radiation Therapy

Creator
Language
Publisher
Date
Source Title
Vol
Issue
First Page
Last Page
Publication Type
Access Rights
JaLC DOI
Related DOI
Related URI
Related HDL
Abstract Purpose. To investigate the clinical outcomes and feasibility of combined conventional radiation therapy (RT) and hypofractionated inverse planned stereotactic radiation therapy (SRT) for locally adva...nced or recurrent adenoid cystic carcinomas (ACCs) of the head and neck. Patients and methods. Five patients with ACCs of the head and neck were treated with combined conventional RT and inverse planned SRT. Radiation doses of 40 to 50 Gy were delivered with 20 to 25 fractions using conventional RT, and then an additional 20 to 25 Gy was delivered by 4 to 5 fractions of SRT. Results. Median follow-up was 12 months. Local control was obtained in all 5 patients, PR in 2 patients and SD in 3 patients. According to the Radiation Therapy Oncology Group (RTOG) late-radiation morbidity scoring criteria, adverse effects included Grade 2 xerostomia in 1 patient, Grade 2 trismus in 1 patient, and Grade 4 mucosal ulceration in 1 patient. Conclusion. Combined treatment with conventional RT and hypofractionated inverse planned SRT may be effective for short-term local control in patients with locally advanced or recurrent ACCs. Further evaluation is needed for long-term follow-up.
目的放射線抵抗性である頭頚部領域の腺様.胞癌に対する通常分割照射+サイバーナイフによるインバースプラン低分割定位照射追加の治療成績を検討する.対象と方法九州大学病院放射線科にて2006 年12 月から2007 年9月までに放射線治療を施行した頭頚部領域の腺様.胞癌5例を対象とした.平均年齢61.4 歳(53-73 歳),男性2例,女性3例,部位は上顎洞2例,中咽頭2例,耳下腺1例で,初発2例,再発3例であった.放射線治療通常分割照射を先行後,腫瘍遺残部にサイバーナイフによる低分割定位照射を追加した.通常分割照射線量は40-50Gy(20-25分割),低分割定位照射追加線量は20-25Gy(4-5分割)で,総線量はα/β=10としてBiological effective doseは78.0.97.5Gy(86.4± 6.3)であった.観察期間中央値は12ケ月(8.18 ケ月)であった.結果腫瘍縮小は全例にみられ,局所制御は100%であった(PR2例,SD3例).1例で照射野外に再発を認め追加放射線治療が施行され,肺・肝転移の1 例は放射線治療後に全身化学療法が施行された.有害事象はRTOGGrade 2 の唾液分泌障害1例,Grade 2の顎関節症1例,Grade 4の粘膜潰瘍を認めた.考察放射線抵抗性腫瘍である腺様.胞癌に対する放射線治療は,通常分割照射のみでは局所制御が充分に得られない可能性があるが,本報告ではサイバーナイフによる低分割定位照射の併用により良好な局所一次効果が確認され,有害事象も許容できると考えられた.今後は長期の腫瘍制御および晩期有害事象の評価が必要と考えられた.
show more

Hide fulltext details.

pdf fam100-2_p059 pdf 2.51 MB 597  

Details

PISSN
NCID
Record ID
Peer-Reviewed
Related PubMed ID
Subject Terms
Type
Created Date 2009.04.22
Modified Date 2021.07.28

People who viewed this item also viewed